Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 4.06 USD 0.25% Market Closed
Market Cap: 620.4m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Mereo Biopharma Group PLC
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Interest Income Expense Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Interest Income Expense
-ÂŁ2.9m
CAGR 3-Years
71%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Interest Income Expense
$570k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Interest Income Expense
-$29m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Interest Income Expense
$27.8m
CAGR 3-Years
N/A
CAGR 5-Years
110%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Interest Income Expense
-ÂŁ344k
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Interest Income Expense
-ÂŁ200k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
24%

See Also

What is Mereo Biopharma Group PLC's Interest Income Expense?
Interest Income Expense
-2.9m GBP

Based on the financial report for Dec 31, 2023, Mereo Biopharma Group PLC's Interest Income Expense amounts to -2.9m GBP.

What is Mereo Biopharma Group PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-12%

The average annual Interest Income Expense growth rates for Mereo Biopharma Group PLC have been 71% over the past three years , -12% over the past five years .

Back to Top